Pancreatic cancer associated micro-RNA
DOI:
https://doi.org/10.54097/hset.v14i.1600Keywords:
Pancreatic cancer, micro-RNA, targeted therapy.Abstract
Pancreatic cancer, known as the king of cancer, is a common malignant tumor of digestive tract, with a high degree of malignancy, difficult diagnosis and treatment, and a 5-year survival rate1%, is one of the malignancies with the worst prognosis. Therefore, there is an urgent need for better methods to improve the diagnostic accuracy and better prognosis of pancreatic cancer. Targeted therapy and accurate monitoring of prognosis is one of the key topics of research. Since 2004, when the relationship between micro-RNA and cancer was first revealed, there has been a great deal of interest in the research of micro-RNA. Related categories have been identified as being associated with other cancers, such as lung cancer, and drugs that use micro-RNA to treat cancer have emerged, but only during clinical trials. In this review, we will discuss the relationship between micro-RNA and pancreatic cancer and specifically elaborate microRNA-125a-5p、microRNA-125b、 microRNa-423-3p、microRNa-let-7a. At the same time, we summarize the difficulties in using microRNA for targeted therapy and the current clinical situation.
Downloads
References
Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions in- volved in cancers [J]. Proc Natl Acad Sci USA2004.101(9).2999-3004.
MicroRNA antitumor therapy: A review [J]. Chinese Journal of Oncology,202,49(09):454.
Shen Nan, Study on the mechanism of mirNA-125A-5P in the pathogenesis of systemic lupus erythematosus. Shanghai, Shanghai Institute of Biological Sciences, Chinese Academy of Sciences,2012-04-16.
Pan Lujuan, Liang Huayi, Liu Dongju, Zhou Qinghong, Zheng Bin, Qin Yueqiu. Effects of mirNA-125A-5P on the expression of Caspase-8 in subcutaneous transplanted pancreatic cancer cells [J]. Journal of Youjiang Medical College for Nationalities,202,44(01):16-19+24.
Sun Jie. Molecular mechanism of micrornA-125b down-regulation of BAK1 and inhibition of pancreatic cancer cell apoptosis [D]. Nanjing Medical University,2013.
Wang Yunfeng, Man Xiaohua, Gao Jun, Du Yi-qi, Li Zhaoshen, Jin Jing, Wu Hongyu. Expression and significance of Bcl-2 P_(53) protein in pancreatic cancer [J]. Chinese Journal of Experimental Surgery,1996(05):263-264+326-327.
Xu Weixian, He Zhiwei, Yu Chao, Tian She, Chen Shiyu, Pan Yaozhen, Sun Chengyi, et al. The role of microRNA-125B in the invasion and metastasis of pancreatic cancer [J]. Journal of guizhou university of medical sciences, 2019, 44 (8) : 881-885. The DOI: 10.19367 / j.carol carroll nki. 1000-2707.2019.08.003.
Qin Yi, Liang Dingkong, SHI Si, Ji Shunrong, Zhang Bo, Xu Wenyan, Liu Jiang, Xu Jin, Ni Quanxing, Yu Xianjun. Effects of e-cadherin /β-catenin on glycolysis of pancreatic cancer cells [J]. Chinese journal of cancer,2015,25(02):81-86.
Zhao Nan, Zhang Tao, Wei Dong, Gao Chunfang, et al. Mir-423-3p regulates the sensitivity of colon cancer cells to 5-FU by targeting SUFU [J]. Chinese journal of histochemistry and cytochemistry, 2021, 30 (02) : 152-158. The DOI: 10.16705 / j.carol carroll nki. 1004-1850.2021.02.006.
Ma Dan, Man Xiaohua, Gao Jun, Li Zhaoshen. Expression and clinical significance of Shh, Gli1, Sufu, TAK1 and P-TAK1 in pancreatic cancer [J]. Chinese journal of pancreatic disease,2013,13(04):240-243.
Wang liang. Study on the mechanism of mirNA-423-3P targeting ISG15 on PD-L1 in pancreatic cancer [J]. University of south China, 2021. DOI: 10.27234 /, dc nki. Gnhuu. 2021.001035.
Sun Jia. Downregulation of TRIM29 expression inhibits stem cell-like phenotype of pancreatic ductal adenocarcinoma by promoting ISG15 protein degradation [D]. China medical university, 2020. DOI: 10.27652 /, dc nki. Gzyku. 2020.000140.
Mao Xingbo, Sheng Tao, Zhuang Liping, Wu Changkang, Zhao Guogang. Expression of miRNA LET-7A and HMGA2 in pancreatic cancer and its diagnostic value in serum [J]. Journal of sichuan university medical science,2020,51(04):540-545.
Wang Yunliang, Li Cui. et al. Expression of HMGA1 and HMGA2 in pancreatic cancer [J]. J clin endocrinol,2017,39(10):1449-1452.
Wang Yinqiu, LiuYan, Hu Youjian. microRNA: a new target for drug development [J]. Shanghai medicine,2012,33(03):31-35.
Ye Qiuwen, Gan Ping, Tan Jing. Research progress of microRNA in diagnosis and treatment of pancreatic cancer [J]. Medical review,2015,21(14):2569-2571.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
